OR WAIT null SECS
Adam C. Fisher, Phd, is Director of Science Staff, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA.
December 16, 2022
Some manufacturers are developing smaller, more mobile drug manufacturing processes for point-of-use patient care.
September 22, 2022
FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.